Matthias Koepp

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Wolfgang Löscher

Professor and Chair

University of Veterinary Medicine

GERMANY

View details

John S Duncan

University College London

UNITED KINGDOM

View details

Helge Müller-Fielitz

University of Lübeck

GERMANY

View details

Markus Schwaninger

University of Lübeck

GERMANY

View details

torbjörn Tomson

Karolinska Institutet

SWEDEN

View details

Annamaria Vezzani

Head of Experimental Neurology Laboratory

Istituto di Ricerche Farmacologiche Mario Negri

ITALY

View details

Gavin Winston

Professor of Neurology

Queen's University

CANADA

View details

Piero Perucca

AUSTRALIA

View details

Johan Zelano

Professor of neurology

University of Gothenburg

SWEDEN

View details

Meneka Kaur Sidhu

University College London

UNITED KINGDOM

View details

Emilio Perucca

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthias Koepp

Research Interests

Explore related searches

Contact this professor

Articles (16)

The effect of cortical and subcortical parcel volumes on postictal generalized EEG suppression

Academia, industry and the slow adoption of new treatments

Clinical trials of prevention of acquired epilepsy: New proof‐of‐concept approach to restart trials

Distinct gray matter and metabolic characteristics in hypothalamic hamartoma network with different semiology

The upside of epilepsy: Theories of an evolutionary paradox

New epilepsy therapies in development

Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). II. Drugs in more advanced clinical development

Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). I. Drugs in preclinical and early clinical development

Pathophysiology, Diagnosis, Prognosis, and Prevention of Poststroke Epilepsy

Tolerability of tariquidar – a third generation P-gp inhibitor as add-on medication to antiseizure medications in drug-resistant epilepsy

Progressive postoperative atrophy of ipsilateral thalamus, putamen, and globus pallidus in patients with temporal lobe epilepsy: A volumetric analysis

Antiepileptogenesis after stroke—trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate

In atrial fibrillation epilepsy risk differs between oral anticoagulants: active comparator, nested case-control study

Episodic memory network connectivity in temporal lobe epilepsy

Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): I. Drugs in preclinical and early clinical development

Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): II. Drugs in more advanced clinical development

Collaborators (11)

Wolfgang Löscher

John S Duncan

Helge Müller-Fielitz

Markus Schwaninger

torbjörn Tomson

Annamaria Vezzani

Gavin Winston

Piero Perucca

Johan Zelano

Meneka Kaur Sidhu

Emilio Perucca

Make your next move.